Squarepoint Ops LLC Sells 92,264 Shares of Accolade, Inc. (NASDAQ:ACCD)

Squarepoint Ops LLC reduced its position in Accolade, Inc. (NASDAQ:ACCD) by 62.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 56,630 shares of the company’s stock after selling 92,264 shares during the quarter. Squarepoint Ops LLC owned approximately 0.07% of Accolade worth $194,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently made changes to their positions in ACCD. Laird Norton Wetherby Trust Company LLC bought a new position in shares of Accolade during the 4th quarter worth $38,000. Boothbay Fund Management LLC purchased a new stake in Accolade during the fourth quarter valued at about $43,000. Pilgrim Partners Asia Pte Ltd bought a new position in Accolade during the fourth quarter worth about $54,000. RPO LLC purchased a new position in shares of Accolade in the fourth quarter worth about $57,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd raised its position in shares of Accolade by 49.9% in the fourth quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd now owns 17,804 shares of the company’s stock valued at $61,000 after purchasing an additional 5,929 shares during the period. 84.99% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts recently commented on ACCD shares. Piper Sandler downgraded shares of Accolade from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 5th. Stephens restated an “equal weight” rating and set a $7.03 target price on shares of Accolade in a research report on Wednesday, February 12th. Thirteen investment analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $6.51.

Accolade Price Performance

ACCD opened at $7.02 on Monday. The firm has a market capitalization of $575.59 million, a P/E ratio of -3.12 and a beta of 2.10. Accolade, Inc. has a one year low of $3.08 and a one year high of $7.03. The company has a fifty day moving average price of $7.02 and a 200-day moving average price of $6.18. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.63 and a quick ratio of 2.63.

Accolade Company Profile

Accolade, Inc, together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and primary care physicians.